AU2008905378A0 - Compositions and methods for treatment of kidney disorders - Google Patents

Compositions and methods for treatment of kidney disorders

Info

Publication number
AU2008905378A0
AU2008905378A0 AU2008905378A AU2008905378A AU2008905378A0 AU 2008905378 A0 AU2008905378 A0 AU 2008905378A0 AU 2008905378 A AU2008905378 A AU 2008905378A AU 2008905378 A AU2008905378 A AU 2008905378A AU 2008905378 A0 AU2008905378 A0 AU 2008905378A0
Authority
AU
Australia
Prior art keywords
compositions
treatment
methods
kidney disorders
kidney
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2008905378A
Inventor
Karen Annette Duggan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vectus Biosystems Pty Ltd
Original Assignee
Vectus Biosystems Pty Ltd
Filing date
Publication date
Application filed by Vectus Biosystems Pty Ltd filed Critical Vectus Biosystems Pty Ltd
Publication of AU2008905378A0 publication Critical patent/AU2008905378A0/en
Priority to KR1020117011192A priority Critical patent/KR101671406B1/en
Priority to ES09820116.3T priority patent/ES2603963T3/en
Priority to MYPI2011001651A priority patent/MY160560A/en
Priority to CN2009801410744A priority patent/CN102186496A/en
Priority to DK09820116.3T priority patent/DK2349320T3/en
Priority to SG10201501316VA priority patent/SG10201501316VA/en
Priority to AU2009304595A priority patent/AU2009304595B2/en
Priority to US13/124,139 priority patent/US8569235B2/en
Priority to PCT/AU2009/001367 priority patent/WO2010042997A1/en
Priority to JP2011531304A priority patent/JP2012505835A/en
Priority to NZ603602A priority patent/NZ603602A/en
Priority to CA2740989A priority patent/CA2740989C/en
Priority to BRPI0914504A priority patent/BRPI0914504B8/en
Priority to EP09820116.3A priority patent/EP2349320B1/en
Priority to MX2011004031A priority patent/MX336384B/en
Priority to NZ592612A priority patent/NZ592612A/en
Priority to RU2011114857/15A priority patent/RU2519124C2/en
Priority to IL212353A priority patent/IL212353A0/en
Priority to ZA2011/03572A priority patent/ZA201103572B/en
Priority to HK12100865.8A priority patent/HK1160598A1/en
Priority to US14/034,706 priority patent/US9238054B2/en
Priority to IL235888A priority patent/IL235888A/en
Abandoned legal-status Critical Current

Links

AU2008905378A 2008-10-17 2008-10-17 Compositions and methods for treatment of kidney disorders Abandoned AU2008905378A0 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
JP2011531304A JP2012505835A (en) 2008-10-17 2009-10-16 Compositions and methods for the treatment of renal disorders
MYPI2011001651A MY160560A (en) 2008-10-17 2009-10-16 Compositions and methods for treatment of kidney disorders
RU2011114857/15A RU2519124C2 (en) 2008-10-17 2009-10-16 Compositions and methods of treating renal disorders
NZ603602A NZ603602A (en) 2008-10-17 2009-10-16 Compositions and methods for treatment of kidney disorders
CN2009801410744A CN102186496A (en) 2008-10-17 2009-10-16 Compositions and methods for treatment of kidney disorders
DK09820116.3T DK2349320T3 (en) 2008-10-17 2009-10-16 Compositions and methods for the treatment of renal disorders
SG10201501316VA SG10201501316VA (en) 2008-10-17 2009-10-16 Compositions and methods for treatment of kidney disorders
AU2009304595A AU2009304595B2 (en) 2008-10-17 2009-10-16 Compositions and methods for treatment of kidney disorders
US13/124,139 US8569235B2 (en) 2008-10-17 2009-10-16 Treatment of kidney disorders with VIP fragments
PCT/AU2009/001367 WO2010042997A1 (en) 2008-10-17 2009-10-16 Compositions and methods for treatment of kidney disorders
BRPI0914504A BRPI0914504B8 (en) 2008-10-17 2009-10-16 use of a vasoactive intestinal peptide (piv) or one or more functional fragments of the piv
KR1020117011192A KR101671406B1 (en) 2008-10-17 2009-10-16 Compositions and methods for treatment of kidney disorders
CA2740989A CA2740989C (en) 2008-10-17 2009-10-16 Compositions and methods for treatment of kidney fibrosis comprising vasoactive intestinal peptide (vip) or functional vip fragments
ES09820116.3T ES2603963T3 (en) 2008-10-17 2009-10-16 Compositions and methods for the treatment of renal disorders
EP09820116.3A EP2349320B1 (en) 2008-10-17 2009-10-16 Compositions and methods for treatment of kidney disorders
MX2011004031A MX336384B (en) 2008-10-17 2009-10-16 Compositions and methods for treatment of kidney disorders.
NZ592612A NZ592612A (en) 2008-10-17 2009-10-16 Vasoactive intestinal peptide (VIP) Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-X for the treatment of kidney disorders
IL212353A IL212353A0 (en) 2008-10-17 2011-04-14 Compositions and methods for treatment of kidney disorders
ZA2011/03572A ZA201103572B (en) 2008-10-17 2011-05-16 Compositions and methods for treatment of kidney disorders
HK12100865.8A HK1160598A1 (en) 2008-10-17 2012-01-31 Compositions and methods for treatment of kidney disorders
US14/034,706 US9238054B2 (en) 2008-10-17 2013-09-24 Treatment of kidney fibrosis with VIP fragments
IL235888A IL235888A (en) 2008-10-17 2014-11-25 Use of vasoactive intestinal peptide (vip) fragments in the manufacture of compositions for treatment of kidney fibrosis

Publications (1)

Publication Number Publication Date
AU2008905378A0 true AU2008905378A0 (en) 2008-11-06

Family

ID=

Similar Documents

Publication Publication Date Title
IL258730A (en) Compositions and methods for treatment of microbial disorders
EP2293800A4 (en) Compositions and methods for treatment of ear disorders
WO2011049960A9 (en) Compositions and methods for the treatment of sinonasal disorders
EP2315780B8 (en) Compositions and methods of use for therapeutic antibodies
EP1977746B8 (en) Methods and compositions for reduction of side effects of therapeutic treatments
EP2259679A4 (en) Methods for treatment of kallikrein-related disorders
HK1160598A1 (en) Compositions and methods for treatment of kidney disorders
EP2361089A4 (en) Compositions and methods for the treatment of altered -synuclein function
WO2010042548A9 (en) Methods of treating inflammation
WO2011071995A9 (en) Compounds and methods of treating ocular disorders
WO2007101161A8 (en) Methods and compositions for the treatment of gastrointestinal disorders
EP2340027A4 (en) Methods and compositions for the treatment of cancer
AU2010260585A8 (en) Compositions and methods for treatment of Multiple Sclerosis
EP2296682B8 (en) Methods of treating ophthalmic disorders
AU2009223851A8 (en) Methods of treating hyperacidic disorders
EP2370087A4 (en) Methods and compositions for the treatment of fluid retention disorders
AU2008905378A0 (en) Compositions and methods for treatment of kidney disorders
GB0808326D0 (en) Compositions and methods for the treatment of fybromyalgia
AU2007901739A0 (en) Methods and compositions for treatment of menorrhagia
AU2008902372A0 (en) Methods of treatment
AU2007901740A0 (en) Compositions and methods for treatment of miscarriage
AU2007905725A0 (en) Methods and compositions for treating disorders of glucose homeostasis
IL209658A0 (en) Compositions and methods for treatment of ear disorders
AU2007900995A0 (en) Therapeutic Compositions and Methods of Treatment
AU2007900455A0 (en) Compounds and Methods of Treatment